Designs and sells mattresses directly to consumers. Offers a variety of pillows, sheets, and bedding products. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 26% a year over the last 3 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 43% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 26% a year on average.
Sales run at $497M a year. A small number, but proof the product has real buyers.
A loss of $89.6M against $497M in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.